Mirae Asset Global ETFs Holdings’s SpringWorks Therapeutics SWTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45,233	Closed	-$2.13M	–	3152
2025 Q2	$2.13M	Sell	45,233 -844	-2%	-$37.5K	﹤0.01%	1064
2025 Q1	$2.05M	Buy	46,077 +2,064	+5%	+$95K	﹤0.01%	1120
2024 Q4	$1.59M	Buy	44,013 +931	+2%	+$32.5K	﹤0.01%	1276
2024 Q3	$1.38M	Buy	43,082 +3,046	+8%	+$114K	﹤0.01%	1354
2024 Q2	$1.51M	Buy	+40,036	New	+$1.69M	﹤0.01%	1219

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SWTX Position: Q3 2025 in Review

Mirae Asset Global ETFs Holdings sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 45,233 shares — an estimated $2.13M sold.

Mirae Asset Global ETFs Holdings first reported a position in SWTX in Q2 2024 and held it in 5 quarters. The position peaked at $2.13M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Mirae Asset Global ETFs Holdings reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 45,233 SpringWorks Therapeutics shares in Q3 2025, an estimated $2.13M.
Mirae Asset Global ETFs Holdings first reported a position in SpringWorks Therapeutics in Q2 2024 and held it in 5 quarters.
Mirae Asset Global ETFs Holdings's SpringWorks Therapeutics position peaked at $2.13M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.